|
|
|
|
Founder, Director of Research and Analyst enters his fifth (5) year with Scimitar Equity, LLC He was until 2002, a Vice President - Strategic Planning and Communication at Curis, Inc. where he was responsible for the first restructuring and the second realignment. Henry worked with Hambrecht and Quist Capital Management (HQCM) focusing on healthcare investments (NYSE:HQH/HQL) from 1986 through 2000. He also founded LifeScience Economics, a healthcare research and analytics firm with offices in Boston, MA and Palo Alto, CA. Past experiences include manager/director at Thermo Electron, and Stone and Webster following five years at the Federal Bureau of Investigation. A former military officer, Henry has been an adjunct professor at Boston University and Golden Gate University where he taught courses in venture capital, corporate finance and strategic development in the universities' graduate business schools. From 1990 to 2003, Henry was responsible for eleven (11) public offerings and seven (7) turnarounds such as: Curis (CRIS), Metra Biosystems (MTRA), later sold to Nexstar; Maxwell Technologies (MXWL); Technology Modeling Associates (TMAI), sold to Avanti; Neurobiological Technologies (NTII); Progenitor (PGEN), assets sold to Cambridge Antibody Technology; VIMRx Pharmaceuticals and sixteen (16) private equity investments.
|
|
|
